LATEST ALERTS
Sports supplement chain puts CBD products into malls across US
6th May 2019 - News analysis |
A major sports supplement chain is the latest business to bring CBD to its shelves in the US
Companies
Willie Nelson expands; high finance; ‘high’ burger; biosynthetic CBD
1st May 2019 - News analysis |
CBD-Intel News in Brief from the US, Canada and UK
Mile High sets up UK operations in Belfast, with London opening next
30th April 2019 - News analysis |
One of the largest CBD companies in the US has opened up a UK base in Northern Ireland, and is on the brink of setting up another in London
Hemp growing on the rise, but Ireland still sends abroad for medical supplies
25th April 2019 - News analysis |
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
Brits back CBD for health; hemp seeds can be imported in US; German raids
23rd April 2019 - News analysis |
CBD-Intel News in Brief from the UK, US and Germany
How social media influencers can make fame pay in the CBD market
22nd April 2019 - News analysis |
Social media influencers are the marketing medium of the moment, and the CBD market is especially well suited to cashing in on the fame and popularity of this new form of advertising
New regulation kick-starts CBD and cannabis industry in Peru
19th April 2019 - News analysis |
As a potential CBD and cannabis market emerges in Peru, players from across the globe are seeing a valuable opportunity for investing in the country
Social difficulties – how the big networks get in a tangle over CBD
15th April 2019 - News analysis |
CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude
Swedish firms rein in dietary sales and health claims until courts decide
9th April 2019 - News analysis |
Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits
Mile High accuses rival CBD firm of copyright infringement and deceit
1st April 2019 - News analysis |
Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges
Mainstream US drugstore chains announce plans to sell CBD
29th March 2019 - News analysis |
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
Canadian company Isodiol buys up California’s CBD Naturals
21st March 2019 - News analysis |
Isodiol International, a large-scale CBD distributor based in Vancouver, Canada, has announced that it has acquired the brand and portfolio of California-based CBD Naturals
All time high in sales for CBD’s new player Turning Point Brands
21st March 2019 - News analysis |
An e-cig company that has recently entered the CBD arena has reported record increases in sales and profit
Europe’s biggest extraction plant opens in Sicily with Canadian backing
19th March 2019 - News analysis |
A new hemp extraction facility, said to be the largest in Europe, has opened in the Sicilian province of Ragusa for the production of CBD-containing products such as oils, cosmetics, and pharmaceuticals
Swiss company plans final appeal against 25% tax on cannabis flowers
19th March 2019 - News analysis |
An appeal is planned against a Swiss court’s decision that low-THC cannabis flowers should continue to be taxed at the same 25% rate as fine-cut tobacco – a decision that came as no surprise to most Swiss CBD companies
CBD can be light at the tunnel’s end for US cannabis and pharma firms
18th March 2019 - News analysis |
A series of year-end results from cannabis-related companies in the US demonstrates the importance of CBD to the bottom line, with volatility in much of the rest of the cannabis and pharmaceutical sectors
There’s room yet for growth and untangling in Canada’s legal reform
18th March 2019 - News analysis |
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Berkeley team hold out hope for cannabinoids synthesised from yeast
14th March 2019 - News analysis |
Obscure cannabinoids and even completely new ones could be produced synthetically from yeast, along with THC and CBD, according to scientists at the University of California in Berkeley
Jelly bean king Klein is hoping for the sweet smell of CBD success
13th March 2019 - News analysis |
David Klein, the man who created the iconic Jelly Belly jelly bean in the 1970s, has entered the CBD edibles market with his latest start-up Spectrum Confections, established to make CBD jelly beans
Big dollars are undeterred by red tape tangle and inconsistent enforcement
11th March 2019 - News analysis |
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses
CBD to treat concussion disorders? Retired NHL players join study
8th March 2019 - News analysis |
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders
Takeovers and investments bloom as hemp takes root across North America
5th March 2019 - News analysis |
North American companies such as Canadian firms Tilray and SOL Global, and Chicago-based Cresco Labs, are all starting or expanding their cannabidiol interests
GW Pharmaceuticals reports loss despite success of CBD-based drug
1st March 2019 - News analysis |
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
Deal signals plans for ‘sustainable’ bio-synthesised CBD
26th February 2019 - News analysis |
The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners and medicines from sugars using a yeast-based process, and it is thought it will do the same with CBD. While the company » Continue Reading.
Cannabis companies team up with pharma firm to supply Europe
14th February 2019 - News analysis |
Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market
CBD company signs deal with mall giant to open branded stores across US
13th February 2019 - News analysis |
Ohio-based CBD and cannabis company Green Growth Brands (GGB) is to open 108 retail locations in shopping malls across the US this year, including some of the most high-profile shopping locations in the country
Israel can grow its cannabis and CBD sector with government blessing
7th February 2019 - News analysis |
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Greek enforcement hurdles hamper but don’t shut down opportunities
6th February 2019 - News analysis |
Interest in the Greek CBD market continues to grow despite an uncertain regulatory situation, with a number of apparent cases of police taking action against people acting entirely legally
Israel gears up for trade after cannabis export law is passed
5th February 2019 - News analysis |
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Biofuel link to Canadian-Italian hemp-growing project
30th January 2019 - News analysis |
Hemp plants in Italy used for the production of CBD are being grown in buildings heated with biofuel
Argentina – land of opportunity beset by confusion and doubt
29th January 2019 - News analysis |
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
CBD to enter the big-time with coffee ads at the Super Bowl
28th January 2019 - News analysis |
A series of advertisements for CBD products will be seen at Sunday’s Super Bowl LIII between the New England Patriots and the LA Rams, powerfully demonstrating their arrival in the US mainstream
Kosher product approval achieved by two CBD companies
25th January 2019 - News analysis |
Two CBD products have received kosher status from the largest agency in Europe dealing with rabbinically-approved foodstuffs.
London-based Advance Biotech received kosher certification from KLBD Kosher Certification in September 2018, followed by Provocan, a CBD brand made by Jerusalem-based company Ciitech, later in the year.
Because CBD oils are ingested orally, they require kosher certification.
LloydsPharmacy may be path to stronger CBD for UK supermarkets
21st January 2019 - News analysis |
Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.
Liposome-based oils ‘deliver CBD four times faster’, manufacturer claims
15th January 2019 - News analysis |
A Swiss CBD company claims to have become the first cannabidiol firm to use liposomes to deliver the substance into users’ bodies and says its new products will deliver CBD to a user’s system four times faster than others
UK company raises £7.4m for medicinal cannabis research
15th January 2019 - News analysis |
A British biopharmaceutical company will be trialling the use of CBD and other hemp-based products for treating opioid addiction, as well as other conditions
Online seller accuses others of using CBD as ‘a marketing tool’
10th January 2019 - News analysis |
The co-founder of an online CBD shop has accused rivals of deceptive marketing. Johan Obel of TheDrug.Store also called for more clarity – and tighter controls – over what is and is not legal in the UK
CBD online in the Netherlands: a more mature market dominated by oils
7th January 2019 - Market reports |
CBD-Intel’s survey of the Dutch CBD online sales channel looks at one of Europe’s more mature markets. It reveals which products dominate sales and how websites vary their offer
which types of shop are selling which types of CBD products, and the most widely available brands on offer Dutch CBD online market seems more mature in terms of brands and products than other European CBD markets such as the German, Spanish or French.Online sales of CBD products mainly happen through CBD specialised websites and online head shops.
The online market is dominated by CBD oils. CBD flowers are not widely available online.
The shape of things to come: what 2019 will bring for CBD
31st December 2018 - News analysis |
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
CBD beverage companies step into the future with nanoemulsions
28th December 2018 - News analysis |
Companies which make beverages containing CBD are resorting to new technologies to get around a thorny problem.
CBD is not water soluble, meaning a fatty emulsion needs to be created in order to get the substance to mix with a liquid – but canny companies are using a process called nanemulsion, where the molecule sizes are reduced to enable the CBD to mix better with the drink.
Canadian company threatened with loss of its medical cannabis licence
13th December 2018 - News analysis |
A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country began regulating medical marijuana
US vape company takes a ‘natural’ step into the CBD business
12th December 2018 - News analysis |
Turning Point Brands, one of America’s largest smokeless tobacco and vapour companies, has taken a minority stake in Canadian American Standard Hemp, a company dedicated to CBD products
Tobacco giant looks to the future with $1.8bn stake in cannabis company
12th December 2018 - News analysis |
US tobacco giant Altria has bought a 45% stake in Canadian cannabis company the Cronos Group, with the option to take a majority 55% stake within the next four years
Merger of CBD firms depends on Farm Bill spreading legalisation nationwide
11th December 2018 - News analysis |
The merger of two companies in the US CBD sector – Level Brands and Cure Based Developments – is dependent on the US Farm Bill legalising CBD at federal level
Charlotte’s Web can spread through drugstores, with help of Farm Bill
10th December 2018 - News analysis |
Charlotte’s Web Holdings, which claims to be the market leader in “innovative hemp-based, CBD wellness products”, says it expects to add national drugstores to its thousands of locations in the US soon
CBD products in British health stores: UK cities market survey
10th December 2018 - Market reports |
CBD-Intel conducted a survey of health food shops known to sell CBD in seven of the largest cities in the UK in order to understand the product and brand landscape
Drinkable CBD – a drop of the good stuff, or weak as water?
6th December 2018 - News analysis |
Among a wave of drinkable CBD products released in the UK this year, one of the more controversial is Love Hemp’s CBD-infused bottled water – advertised as being spring water “infused with CBD hemp droplets”
Wayland agrees to take 51% share in UK medical cannabis company
6th December 2018 - News analysis |
Canadian medical cannabis company Wayland Group has agreed to purchase 51% of the British firm Theros Pharma for £27.8m – if it succeeds in gaining a UK cultivation or import licence
Canadian medical cannabis firm purchases $1m Danish licence to grow
4th December 2018 - News analysis |
Canadian company Indivia has announced its first move into the European market after investing in a deal worth more than $1.1m to purchase a licence to grow cannabis in Denmark
Canadian firms put faith and cash in Italian CBD producers
3rd December 2018 - News analysis |
Two Canadian companies with interests in CBD have announced investments in major Italian legal cannabis producers
